Testing safety of AAPB injection in healthy volunteers
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a new injection called AAPB in healthy people to see if it's safe and how the body processes it. If you are a healthy adult between 18 and 45, you may be able to help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- You are a healthy volunteer with no major medical conditions
- Your weight is at least 50 kg (110 lbs) if male, or 45 kg (99 lbs) if female, and your BMI is between 19 and 28
- You agree to use birth control during the study if you can have children
- You have not taken certain medications or supplements in the past 14-30 days
- You are willing to avoid caffeine, alcohol, smoking and follow a study diet
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single dose of a new medicine called HRS-4029 in healthy people. It helps doctors learn how the drug works in the body and if it is safe. Healthy adults aged 18 to 55 may be able to join.
This trial tests an investigational injection called KPCXM18 for people having an acute ischemic stroke. It is given within 12 hours of symptom onset, in addition to standard clot-dissolving treatment, to see if it improves recovery and safety.
This trial studies a protective “conditioning” treatment given during air ambulance transport for people with a suspected large-vessel ischemic stroke. The goal is to reduce further brain injury and preserve more brain tissue while you’re being transported for stroke care.
This trial tests a new oral medication called LWP779 in healthy adults to see if it is safe and how the body processes it. It helps determine the right dose for future studies.
This trial tests a new medication (bevifibatide) to see which dose works best for people having an ischemic stroke who cannot get standard treatments like clot-busting drugs or a procedure to remove the clot. It aims to improve recovery by stopping clots from getting worse.
This trial tests a new medicine called DA414 in healthy people to see if it is safe and how the body processes it. It may help researchers understand the right dose for future studies.
Hear when a new Acute Ischemic Stroke (AIS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.